Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.720
+0.070 (4.24%)
At close: Jun 26, 2026, 4:00 PM EDT
1.745
+0.024 (1.42%)
After-hours: Jun 26, 2026, 7:39 PM EDT
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $73.17 million as of June 26, 2026. Its market cap has increased by 34.11% in one year.
Market Cap
73.17M
Enterprise Value
58.95M
1-Year Change
34.11%
Ranking
Category
Stock Price
$1.72
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from $62.51M to $73.17M, an increase of 17.06%. That is a compound annual growth rate of 2.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 73.17M | -20.21% |
| Dec 31, 2025 | 91.70M | 32.13% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MindWalk Holdings | 78.47M |
| Gossamer Bio | 76.75M |
| Elicio Therapeutics | 76.29M |
| Gain Therapeutics | 74.64M |
| Edesa Biotech | 72.83M |
| Acrivon Therapeutics | 71.91M |
| XBiotech | 70.73M |
| Pliant Therapeutics | 70.05M |